Case Report

Blastoschizomyces capitatus Pneumonia in an Immunocompetent Male

Authors: Todd S. Wills, MD, Amber Degryse, BS, Jenna Lavina, BS, John T. Sinnott, MD

Abstract

Blastoschizomyces capitatus is an emerging fungal pathogen. It has been well characterized as a cause of local and disseminated disease in immunocompromised hosts, especially in the setting of neutropenia. We describe a case of B capitatus pneumonia in an otherwise healthy man and review the clinical presentation, microbiologic characteristics, and treatment strategies for B capitatus infections.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Martino P, Venditti M, Micozzi A, et al. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis 1990;12:570–582.
 
2. D’Antonio D, Piccolomini R, Fioritoni G, et al. Osteomyelitis and intervertebral discitis caused byBlastoschizomyces capitatus in a patient with acute leukemia. J Clin Microbiol 1994;32:224–227.
 
3. Ortiz AM, Sanz-Rodriguez C, Culebras J, et al. Multiple spondylodiscitis caused byBlastoschizomyces capitatus in an allogeneic bone marrow transplantation recipient. J Rheumatol1998;25:2276–2278.
 
4. Chmel F. Fungal infections in the immunocompromised host: clinical syndromes and diagnosis, in Murphy JW, Friedman H, Bendinelli M (eds):Fungal Infections and Immune Responses. New York, Plenum Press, 1993, pp 405–423.
 
5. Liu KL, Herbrecht R, Bergerat JP, et al. Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation. Bone Marrow Transplant 1990;6:219–221.
 
6. Herbrecht R, Liu KL, Koenig H, et al. Trichosporon capitatum septicemia in immunocompromised patients. Pathol Biol 1990;38:585–588.
 
7. D’Antonio D, Mazzoni A, Iocone A, et al. Emergence of fluconazole-resistant strains ofBlastoschizomyces capitatus causing nosocomial infections in cancer patients. J Clin Microbiol1996;34:753–755.
 
8. Polacheck I, Salkin IF, Kitzes-Cohen R, et al. Endocarditis caused by Blastoschizomyces capitatusand taxonomic review of the genus. J Clin Microbiol 1992;30:2318–2322.
 
9. Arnold AG, Gribbin B, De Leval M, et al. Trichosporon capitatum causing recurrent fungal endocarditis. Thorax 1981;36:478–480.
 
10. Naficy AB, Murray HW. Isolated meningitis caused by Blastoschizomyces capitatus. J Infect Dis1990;161:1041–1042.
 
11. Ito T, Ishikawa R, Fujii R, et al. Disseminated Trichosporon capitatum infection in a patient with acute leukemia. Cancer 1988;61:585–588.
 
12. DeMaio J, Coleman L. The use of adjuvant interferon-gamma therapy for hepatosplenicBlastoschizomyces capitatus infection in a patient with leukemia. Clin Infect Dis 2000;31:822–824.
 
13. Salkin IF, Gordon MA, Samsonoff WA, et al. Blastoschizomyces capitatus, a new combination.Mycotaxon 1985;22:375–380.
 
14. D’Antonio D, Romano F, Iacone A, et al. Onychomycosis caused by Blastoschizomyces capitatus. J Clin Microbiol 1999;37:2927–2930.
 
15. Venditti M, Posteraro B, Morace G, et al. In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus. J Chemother 1991;3:13–15.
 
16. Meduri GU, Beals DH, Maijub AG, et al. Protected bronchoalveolar lavage: a new bronchoscopic technique to retrieve uncontaminated distal airway secretions. Am Rev Respir Dis 1991;143:855–864.